Skip to content
healthcare.dev

Nadolol

NDC 59651-251, Nadolol, tablet, from Aurobindo Pharma Limited.

Product NDC
59651-251
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA201893
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-251 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NADOLOL40 mg/1

Pharmacologic classes

Adrenergic beta-Antagonists [MoA]; beta-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
59651-251-0159651025101100 TABLET in 1 BOTTLE (59651-251-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/44c5352d-89f8-4bd3-9479-1069304562ca
  • NADAC price for package 59651025101

    GET /v1/drugs/nadac/59651025101

Use it

Look up 59651-251 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-251 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-251. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.